GL1X · GenesisL1 explorer

MolNFT v2 · #212308 · protein

Structure of heptameric RdrA ring

8HR8 · Archaeal ATPase: “Structure of heptameric RdrA ring”. Electron microscopy at 3.3, 1 ligand (ATP), 20 pockets (best druggability 0.87). MolNFT v2 #212308 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
8HR8
Type
protein
Length
5,839 residues
Chains
7
Method
electron microscopy
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
3.3
Source
Escherichia coli
Molecule
Archaeal ATPase
UniProt
A0A8H9B1T2
Ligands
ATP
Pockets
20 · best druggability 0.87

Structure

electron microscopy · resolution 3.3 · 6 distinct chains · 54% helix, 6% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, DArchaeal ATPaseprotein83653% helix, 7% strandA0A8H9B1T2
CArchaeal ATPaseprotein83554% helix, 7% strandA0A8H9B1T2
EArchaeal ATPaseprotein83354% helix, 6% strandA0A8H9B1T2
FArchaeal ATPaseprotein83554% helix, 6% strandA0A8H9B1T2
GArchaeal ATPaseprotein83054% helix, 6% strandA0A8H9B1T2
HArchaeal ATPaseprotein83454% helix, 6% strandA0A8H9B1T2

Ligands and binding sites

  • ATP · Adenosine-5'-triphosphate · ligand · 5 copies · chains A, D, C, E, F, G, H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19520.870.89129empty
29870.840.85104ATP
35990.840.8990empty
46690.840.8880ATP
55720.830.8970ATP

Interfaces

12 interfaces between chains.

  • E–F · 4855 Ų buried · 45 hydrogen bonds · protein-protein
  • A–D · 4757 Ų buried · 41 hydrogen bonds · protein-protein
  • G–H · 4671 Ų buried · 26 hydrogen bonds · protein-protein
  • F–G · 4529 Ų buried · 40 hydrogen bonds · protein-protein
  • A–C · 4393 Ų buried · 32 hydrogen bonds · protein-protein

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.